MIMS table on the monitoring of ACE inhibitors and angiotensin II antagonists in Primary Care

The table covers the tests required when starting the medicines, until treatment is stabilised, and ongoing monitoring. The recommendations, which are available online and will appear in the September print issue, are summarised from NICE guidelines, CKS and SIGN.

SPS commentary:

This resource is available to registered users. 


Monthly Index of Medical Specialities